Alzheimer's Collaboration — Total Revenue
Biogen Alzheimer's Collaboration — Total Revenue increased by 26.3% to $59.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.3%, from $33.00M to $59.50M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration or improved commercial execution of Alzheimer's therapies, while a decrease may signal competitive pressure, regulatory hurdles, or slower-than-expected patient adoption.
Detailed definition
This metric represents the total recognized revenue generated from products, licensing, or commercial partnerships speci...
Peer comparison
Comparable to specialized neurology or CNS (Central Nervous System) franchise revenues at large-cap biopharmaceutical peers, though often unique due to specific collaboration accounting structures.
biib_segment_alzheimer_s_collaboration_total_revenueHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.80M | $11.80M | $18.60M | $26.70M | $33.00M | $54.90M | $42.70M | $47.10M | $59.50M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +321.4% | +57.6% | +43.5% | +23.6% | +66.4% | -22.2% | +10.3% | +26.3% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | >999% | +365.3% | +129.6% | +76.4% | +80.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's alzheimer's collaboration — total revenue?
- Biogen (BIIB) reported alzheimer's collaboration — total revenue of $59.50M in Q1 2026.
- How has Biogen's alzheimer's collaboration — total revenue changed year-over-year?
- Biogen's alzheimer's collaboration — total revenue increased by 80.3% year-over-year, from $33.00M to $59.50M.
- What does alzheimer's collaboration — total revenue mean?
- Total revenue earned from products and partnerships dedicated to treating Alzheimer's disease.